共 50 条
Novel and Emerging Targeted Therapies of Colorectal Cancer
被引:4
|作者:
Finnberg, Niklas
[1
,2
]
Gokare, Prashanth
El-Deiry, Wafik S.
机构:
[1] Fox Chase Canc Ctr, Lab Translat Oncol & Expt Canc Therapeut, Dept Med Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA
来源:
关键词:
Clinical;
colorectal cancer;
DPYD;
RAS;
targeted therapy;
TRAIL;
D O I:
10.2174/1574884710666151020095911
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The survival rate of patients with colorectal cancer (CRC) is steadily increasing over the past decade. However, CRC continue to be one of the leading causes of cancer-related fatality in the United States. Current targeted strategies offer limited clinical benefits and the overall survival rate for CRC remains low. Improved understanding of the molecular changes associated with CRC that control growth factor signaling and evasion of cell death allow for the development of improved targeted therapy. This review aims to discuss some of the emerging therapies aimed to target CRC.
引用
收藏
页码:279 / 298
页数:20
相关论文